1. Home
  2. DRTS vs AIO Comparison

DRTS vs AIO Comparison

Compare DRTS & AIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$9.73

Market Cap

978.2M

Sector

Health Care

ML Signal

HOLD

Logo Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

AIO

Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

HOLD

Current Price

$28.11

Market Cap

927.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRTS
AIO
Founded
2015
2019
Country
Israel
United States
Employees
121
N/A
Industry
Medical/Dental Instruments
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
978.2M
927.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DRTS
AIO
Price
$9.73
$28.11
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$8.67
N/A
AVG Volume (30 Days)
933.1K
71.2K
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
9.05%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$699.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.87
$20.91
52 Week High
$11.62
$28.31

Technical Indicators

Market Signals
Indicator
DRTS
AIO
Relative Strength Index (RSI) 52.32 68.98
Support Level $6.59 $23.92
Resistance Level $11.48 N/A
Average True Range (ATR) 0.83 0.64
MACD -0.09 0.06
Stochastic Oscillator 39.92 97.70

Price Performance

Historical Comparison
DRTS
AIO

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term, closed-end management investment company. Its investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.

Share on Social Networks: